Provided by Tiger Fintech (Singapore) Pte. Ltd.

RenovoRx Inc

1.40
+0.11508.95%
Post-market: 1.40-0.0010-0.07%16:48 EDT
Volume:214.22K
Turnover:291.10K
Market Cap:51.20M
PE:-3.64
High:1.40
Open:1.29
Low:1.29
Close:1.29
Loading ...

RenovoRx Inc. Announces Second Quarter 2025 Financial Results Release

Reuters
·
Yesterday

RenovoRx Inc. Conducted Annual Stockholders Meeting

Reuters
·
26 Jun

Ramtin Agah, Chief Medical Officer, Reports Acquisition of RenovoRx Inc. Common Shares

Reuters
·
09 Jun

Ascendiant Remains a Buy on RenovoRx (RNXT)

TIPRANKS
·
05 Jun

RenovoRx Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
05 Jun

RenovoRx (RNXT) Receives a Buy from Alliance Global Partners

TIPRANKS
·
19 May

RenovoRx Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow Jones
·
19 May

RenovoRx’s Innovative Drug Delivery and Promising Clinical Trials Earn a Buy Rating

TIPRANKS
·
17 May

RenovoRx Earnings Call: Positive Outlook Amid Growth

TIPRANKS
·
17 May

RenovoRx Reports Promising Q1 2025 Financial Results

TIPRANKS
·
16 May

RenovoRx Reports Strong Q1 2025 Financial Results

TIPRANKS
·
16 May

RenovoRx Reports Q1 2025 Revenue of $200K, Net Loss Widens to $2.4M

Reuters
·
16 May

RenovoRx Q1 EPS $(0.08) Beats $(0.09) Estimate, Sales $197.00K Miss $225.00K Estimate

Benzinga
·
16 May

BRIEF-RenovoRx Q1 Net Income USD -2.4 Million

Reuters
·
16 May

RenovoRx Q1 Operating Income USD 800 Thousand

THOMSON REUTERS
·
16 May

Corrected-RenovoRx Q1 Operating Income USD -3.11 Million (Corrects Amount)

THOMSON REUTERS
·
16 May

RenovoRx Inc. to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase

Reuters
·
14 May

RenovoRx Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
14 May

Press Release: RenovoRx to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET

Dow Jones
·
01 May

RenovoRx Inc. to Host First Quarter 2025 Financial Results Conference Call

Reuters
·
01 May